They discovered that the people who had obesity-related cancer in these four categories (lung, breast, colon, liver) and were also taking GLP-1s to manage diabetes, had a 38% to 50% lower risk of their cancer advancing to stage 4
Six people over 40 tested this product, and none of them even those with sensitive skin reported any issues
Depression scores improved in 74%
Main text Modern GLP-1 receptor agonists and co-agonists (GLP-1 medicines) such as liraglutide, dulaglutide semaglutide, and the GLP-1R/glucose dependent insulinotropic polypeptide receptor (GIPR) co-agonist tirzepatide, were initially developed for the treatment of type 2 diabetes (T2D) due to their actions to increase insulin and decrease glucagon secretion and slow gastric emptying through effects on the pancreas and brain
While steady-state levels are reached within 4 to 5 weeks, clinical effectiveness can vary from person to person
However, you should always consult your healthcare provider before combining these substances to ensure the combination is appropriate for your specific medical situation
